Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

The Relationship between Fatigue and Cytokine Levels in Patients with Acute Myeloid Leukemia.

Khosravi M, Taghvaye Masoumi H, Gholami K, Vaezi M, Hadjibabaei M, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Oct 1;12(4):318-321.

2.

Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK.

Hematol Oncol Stem Cell Ther. 2019 Jan 11. pii: S1658-3876(18)30122-5. doi: 10.1016/j.hemonc.2018.12.003. [Epub ahead of print] Review.

3.

Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.

Mousavi SA, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, Alimoghaddam K, Vaezi M, Kamranzadeh Fumani H, Babakhani D, Tavakoli S.

PLoS One. 2019 Jan 4;14(1):e0208701. doi: 10.1371/journal.pone.0208701. eCollection 2019.

4.

Successful Outcome of Autologous Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors.

Mousavi SA, Abedinzadeh N, Taj L, Kasaeian A, Alimoghaddam K, Vaezi M, Zokaasadi M, Kamranzadeh Fumani H, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):192-196.

5.

The Role of Donor Leukocyte Infusions in the Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation: A Retrospective Analysis.

Vaezi M, Zokaasadi M, Shahsavari Pour S, Kasaeian A, Nikbakht M, Kamranzadeh Fumani H, Alimoghaddam K, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):185-191.

6.

Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings.

Ahmadi A, Kaviani S, Yaghmaie M, Pashaiefar H, Ahmadvand M, Jalili M, Alimoghaddam K, Eslamijouybari M, Ghavamzadeh A.

Blood Res. 2018 Dec;53(4):320-324. doi: 10.5045/br.2018.53.4.320. Epub 2018 Dec 17.

7.

Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT.

Giebel S, Labopin M, Czerw T, Socié G, Blaise D, Ghavamzadeh A, Passweg J, Ljungman P, Poiré X, Chevallier P, Reményi P, Rambaldi A, Anafasyev B, Fegueux N, Rovira M, Itälä-Remes M, Bornhäuser M, Mohty M, Nagler A.

Eur J Cancer. 2019 Jan;106:212-219. doi: 10.1016/j.ejca.2018.11.003. Epub 2018 Dec 6.

PMID:
30528805
8.

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis.

Canaani J, Beohou E, Labopin M, Ghavamzadeh A, Beelen D, Hamladji RM, Niederwieser D, Volin L, Markiewicz M, Arnold R, Mufti G, Ehninger G, Socié G, Kröger N, Mohty M, Nagler A.

J Intern Med. 2018 Oct 29. doi: 10.1111/joim.12854. [Epub ahead of print]

PMID:
30372796
9.

A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens.

Hamidieh AA, Eslami Shahre Babaki A, Rostami T, Kasaeian A, Koochakzadeh L, Sharifi Aliabadi L, Behfar M, Ghavamzadeh A.

Exp Clin Transplant. 2018 Oct 5. doi: 10.6002/ect.2017.0226. [Epub ahead of print]

10.

Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis.

Ghavamzadeh A, Kasaeian A, Rostami T, Kiumarsi A.

Biol Blood Marrow Transplant. 2019 Feb;25(2):307-312. doi: 10.1016/j.bbmt.2018.09.026. Epub 2018 Sep 26.

PMID:
30266673
11.

SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial.

Barkhordar M, Mohammadi M, Hadjibabaie M, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):77-83.

12.

Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients.

Izadifard M, Pashaiefar H, Yaghmaie M, Montazeri M, Sadraie M, Momeny M, Jalili M, Ahmadvand M, Ghaffari SH, Mohammadi S, Alimoghaddam K, Ghavamzadeh A.

Genet Test Mol Biomarkers. 2018 Oct;22(10):593-598. doi: 10.1089/gtmb.2018.0143. Epub 2018 Sep 14.

PMID:
30222365
13.

Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three Institutions.

Jalaeikhoo H, Khajeh-Mehrizi A, Zokaasadi M, Rajaeinejad M, Asadollah Mousavi S, Vaezi M, Kamranzadeh Fumani H, Keyhani M, Alimoghaddam K, Ghavamzadeh A.

Middle East J Dig Dis. 2018 Jul;10(3):160-168. doi: 10.15171/mejdd.2018.105. Epub 2018 May 27.

14.

Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.

Momeny M, Eyvani H, Barghi F, Ghaffari SH, Javadikooshesh S, Hassanvand Jamadi R, Esmaeili F, Alishahi Z, Zaghal A, Bashash D, Samani FS, Ghaffari P, Dehpour AR, Tavangar SM, Alimoghaddam K, Ghavamzadeh A.

Anticancer Drugs. 2018 Nov;29(10):1011-1020. doi: 10.1097/CAD.0000000000000681.

PMID:
30096128
15.

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.

Baldomero H, Aljurf M, Zaidi SZA, Hashmi SK, Ghavamzadeh A, Elhaddad A, Hamladji RM, Ahmed P, Torjemane L, Abboud M, Tbakhi A, Khabori MA, El Quessar A, Bazuaye N, Bekadja MA, Adil S, Fahmy O, Ramzi M, Ibrahim A, Alseraihy A, Ben Abdejalil N, Sarhan M, Huneini MA, Mahmal L, ElSolh H, Hussain F, Nassar A, Al-Hashmi H, Hamidieh AA, Pasquini M, Kodera Y, Kröger N, Mohty M, Jaimovich G, Rolon JM, Paulson K, Greinix H, Weisdorf D, Horowitz M, Nunez J, Gratwohl A, Passweg J, Koh M, Szer J, Niederwieser D, Novitzky N; East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Bone Marrow Transplant. 2019 Mar;54(3):402-417. doi: 10.1038/s41409-018-0275-5. Epub 2018 Aug 6.

PMID:
30082852
16.

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.

Yousefi H, Momeny M, Ghaffari SH, Parsanejad N, Poursheikhani A, Javadikooshesh S, Zarrinrad G, Esmaeili F, Alishahi Z, Sabourinejad Z, Sankanian G, Shamsaiegahkani S, Bashash D, Shahsavani N, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A.

Tumori. 2018 Jul 1:300891618784790. doi: 10.1177/0300891618784790. [Epub ahead of print]

PMID:
30021477
17.

Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.

Mesbahi Y, Zekri A, Ghaffari SH, Tabatabaie PS, Ahmadian S, Ghavamzadeh A.

Eur J Pharmacol. 2018 Sep 5;834:65-76. doi: 10.1016/j.ejphar.2018.07.010. Epub 2018 Jul 19.

PMID:
30012499
18.

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita.

Fioredda F, Iacobelli S, Korthof ET, Knol C, van Biezen A, Bresters D, Veys P, Yoshimi A, Fagioli F, Mats B, Zecca M, Faraci M, Miano M, Arcuri L, Maschan M, O'Brien T, Diaz MA, Sevilla J, Smith O, Peffault de Latour R, de la Fuente J, Or R, Van Lint MT, Tolar J, Aljurf M, Fisher A, Skorobogatova EV, Diaz de Heredia C, Risitano A, Dalle JH, Sedláček P, Ghavamzadeh A, Dufour C.

Br J Haematol. 2018 Oct;183(1):110-118. doi: 10.1111/bjh.15495. Epub 2018 Jul 9.

PMID:
29984823
19.

Significant drug interaction between voriconazole and dexamethasone: A case report.

Taghvaye Masoumi H, Hadjibabaie M, Gholami K, Zarif-Yeganeh M, Ghavamzadeh A.

J Oncol Pharm Pract. 2018 Jan 1:1078155218783248. doi: 10.1177/1078155218783248. [Epub ahead of print]

PMID:
29945531
20.

Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes.

Hassani S, Ghaffari P, Chahardouli B, Alimoghaddam K, Ghavamzadeh A, Alizadeh S, Ghaffari SH.

Biomed Pharmacother. 2018 Mar;99:561-569. doi: 10.1016/j.biopha.2018.01.109. Epub 2018 Feb 20.

PMID:
29902866
21.

PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.

Pashaiefar H, Yaghmaie M, Tavakkoly-Bazzaz J, Ghaffari SH, Alimoghaddam K, Momeny M, Izadi P, Izadifard M, Kasaeian A, Ghavamzadeh A.

Genet Test Mol Biomarkers. 2018 Jun;22(6):343-349. doi: 10.1089/gtmb.2018.0085. Epub 2018 May 29.

PMID:
29812960
22.

FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Ardestani MT, Kazemi A, Chahardouli B, Mohammadi S, Nikbakht M, Rostami S, Jalili M, Vaezi M, Alimoghaddam K, Ghavamzadeh A.

Turk J Haematol. 2018 Aug 3;35(3):158-167. doi: 10.4274/tjh.2018.0017. Epub 2018 May 22.

23.

Photopheresis of a less than 10-kg child with acute graft versus host disease accompanied with hyperbilirubinemia: A case report.

Mohammadi AM, Norooznezhad AH, Seghatchian J, Nikbakht M, Heshmati F, Mohammadi S, Alimoghaddam K, Ghavamzadeh A.

Transfus Apher Sci. 2018 Jun;57(3):428-430. doi: 10.1016/j.transci.2018.05.006. Epub 2018 May 9.

PMID:
29778715
24.

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Sociè G, Bourhis JH, Van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A.

Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

25.

Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells

Mohammadi Kian M, Mohammadi S, Tavallaei M, Chahardouli B, Rostami S, Zahedpanah M, Ghavamzadeh A, Nikbakht M.

Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1127-1134.

26.

Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.

Hamidieh AA, Mohseni F, Behfar M, Hamidi Z, Alimoghaddam K, Pajouhi M, Larijani B, Mohajeri-Tehrani MR, Ghavamzadeh A.

Arch Iran Med. 2018 Feb 1;21(2):56-60.

27.

Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.

Battipaglia G, Ruggeri A, Labopin M, Volin L, Blaise D, Socié G, Tabrizi R, Cornelissen JJ, Ghavamzadeh A, Huynh A, Wu D, Yakoub-Agha I, Maertens J, Chevallier P, Mohty M, Nagler A.

Bone Marrow Transplant. 2018 Oct;53(10):1295-1303. doi: 10.1038/s41409-018-0169-6. Epub 2018 Apr 16.

PMID:
29662244
28.

Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients.

Pashaiefar H, Izadifard M, Yaghmaie M, Montazeri M, Gheisari E, Ahmadvand M, Momeny M, Ghaffari SH, Kasaeian A, Alimoghaddam K, Ghavamzadeh A.

Genet Test Mol Biomarkers. 2018 May;22(5):288-294. doi: 10.1089/gtmb.2017.0281. Epub 2018 Apr 10.

PMID:
29634410
29.

The Association between PARP1 and LIG3 Expression Levels and Chromosomal Translocations in Acute Myeloid Leukemia Patients.

Pashaiefar H, Yaghmaie M, Tavakkoly-Bazzaz J, Hamidollah Ghaffari S, Alimoghaddam K, Izadi P, Ghavamzadeh A.

Cell J. 2018 Jul;20(2):204-210. doi: 10.22074/cellj.2018.5210. Epub 2018 Mar 18.

30.

The effects of lower CD34 yields after lowe dose G-CSF induction on long-term autologous stem cell transplantation outcome: A single center study.

Vaezi M, Shakouri M, Souri M, Setaredan MA, Mossavi SA, Mohammadi S, Alimoghaddam K, Ghavamzadeh A.

Transfus Apher Sci. 2018 Apr;57(2):265-271. doi: 10.1016/j.transci.2018.03.007. Epub 2018 Mar 23.

PMID:
29605509
31.

Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance

Mirzaei A, Mohammadi S, Ghaffari SH, Yaghmaie M, Vaezi M, Alimoghaddam K, Ghavamzadeh A.

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):615-623. Review.

32.

Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.

Momeny M, Yousefi H, Eyvani H, Moghaddaskho F, Salehi A, Esmaeili F, Alishahi Z, Barghi F, Vaezijoze S, Shamsaiegahkani S, Zarrinrad G, Sankanian G, Sabourinejad Z, Hamzehlou S, Bashash D, Aboutorabi ES, Ghaffari P, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.

Int J Biochem Cell Biol. 2018 Jun;99:1-9. doi: 10.1016/j.biocel.2018.03.015. Epub 2018 Mar 19.

PMID:
29567488
33.

Corrigendum to: Comparison of Induction Therapy in Non-high Risk Acute Promyelocytic Leukemia with Arsenic Trioxide or in Combination with ATRA Leukemia Research 66 (2018) 85-88.

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K.

Leuk Res. 2018 Apr;67:116. doi: 10.1016/j.leukres.2018.03.003. No abstract available.

PMID:
29566848
34.

Differentiating and Categorizing of Liposarcoma and Synovial Sarcoma Neoplasms by Fluorescence in Situ Hybridization.

Shahi F, Alishahi R, Pashaiefar H, Jahanzad I, Kamalian N, Ghavamzadeh A, Yaghmaie M.

Iran J Pathol. 2017 Summer;12(3):209-217. Epub 2017 Jul 1.

35.

Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis

Jalili M, Yaghmaie M, Ahmadvand M, Alimoghaddam K, Mousavi SA, Vaezi M, Ghavamzadeh A.

Asian Pac J Cancer Prev. 2018 Feb 26;19(2):325-329. Review.

36.

How do anxiety affect CD34 and CD3 cells in allogeneic peripheral blood stem cell transplantation?

Larijani TT, Mohammadi S, Kasaeian A, Malek Mohammadi A, Mostafaei S, Alimoghaddam K, Ghavamzadeh A.

Transfus Apher Sci. 2018 Feb;57(1):107-110. doi: 10.1016/j.transci.2018.01.006. Epub 2018 Jan 31.

PMID:
29439917
37.

Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K.

Leuk Res. 2018 Mar;66:85-88. doi: 10.1016/j.leukres.2018.01.019. Epub 2018 Feb 3. Erratum in: Leuk Res. 2018 Apr;67:116.

PMID:
29407588
38.

Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).

Shahkarami S, Mehrasa R, Younesian S, Yaghmaie M, Chahardouli B, Vaezi M, Rezaei N, Nikbakht M, Alimoghaddam K, Ghavamzadeh A, Tavakkoly-Bazzaz J, Ghaffari SH.

Ann Hematol. 2018 Apr;97(4):585-595. doi: 10.1007/s00277-018-3230-z. Epub 2018 Feb 1.

PMID:
29392424
39.

Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.

Behfar M, Faghihi-Kashani S, Hosseini AS, Ghavamzadeh A, Hamidieh AA.

Biol Blood Marrow Transplant. 2018 Apr;24(4):866-870. doi: 10.1016/j.bbmt.2017.12.786. Epub 2017 Dec 25.

PMID:
29284143
40.

Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.

Mesbahi Y, Zekri A, Ahmadian S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.

Eur J Pharmacol. 2018 Feb 5;820:274-285. doi: 10.1016/j.ejphar.2017.12.041. Epub 2017 Dec 20.

PMID:
29274334
41.

Treatment of vincristine-induced ileus with metoclopramide: A case report.

Masoumi HT, Hadjibabaie M, Zarif-Yeganeh M, Khajeh B, Ghavamzadeh A.

J Oncol Pharm Pract. 2017 Jan 1:1078155217746228. doi: 10.1177/1078155217746228. [Epub ahead of print]

PMID:
29224457
42.

Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells

Salemi M, Mohammadi S, Ghavamzadeh A, Nikbakht M.

Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3055-3061.

43.

An alternative method for custom prime: A case report of successful peripheral blood stem cell harvesting from two low-weight child donors.

Mohammadi AM, Norooznezhad AH, Aminian P, Nikbakht M, Chahardouli B, Rostami S, Heshmati F, Mohammadi S, Ghavamzadeh A.

Transfus Apher Sci. 2017 Dec;56(6):886-888. doi: 10.1016/j.transci.2017.11.003. Epub 2017 Nov 8.

PMID:
29162400
44.

Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).

Hassani S, Khaleghian A, Ahmadian S, Alizadeh S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.

Ann Hematol. 2018 Jan;97(1):83-93. doi: 10.1007/s00277-017-3163-y. Epub 2017 Nov 20.

PMID:
29159499
45.

Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major.

Ghavamzadeh A, Sotoudeh M, Hashemi Taheri AP, Alimoghaddam K, Pashaiefar H, Jalili M, Shahi F, Jahani M, Yaghmaie M.

Ann Hematol. 2018 Feb;97(2):327-334. doi: 10.1007/s00277-017-3181-9. Epub 2017 Nov 17.

PMID:
29150810
46.

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A.

J Intern Med. 2018 Feb;283(2):166-177. doi: 10.1111/joim.12695. Epub 2017 Nov 3.

PMID:
29027756
47.

Impact of CYP2C19 Polymorphisms on Serum Concentration of Voriconazole in Iranian Hematological Patients.

Ebrahimpour S, Namazi S, Mohammadi M, Nikbakht M, Hadjibabaie M, Masoumi HT, Ghavamzadeh A.

J Res Pharm Pract. 2017 Jul-Sep;6(3):151-157. doi: 10.4103/jrpp.JRPP_17_31.

48.

High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome.

Seyedalipour F, Mansouri A, Vaezi M, Gholami K, Heidari K, Hadjibabaie M, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):209-216.

49.

How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?

Vaezi M, Kasaeian A, Souri M, Soufiyan F, Shokri Boosjin A, Setarehdan SA, Alimoghaddam K, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):199-208.

50.

OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment

Mirzaei A, Ghaffari SH, Nikbakht M, Kamranzadeh Foumani H, Vaezi M, Mohammadi S, Alimoghaddam K, Ghavamzadeh A.

Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2591-2599.

Supplemental Content

Loading ...
Support Center